.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Cerilliant
Healthtrust
Merck
Chubb
Argus Health
QuintilesIMS
McKinsey
Queensland Health
Moodys

Generated: February 25, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: naproxen sodium; pseudoephedrine hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
PerrigoNAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDEnaproxen sodium; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL076518ANDAL. Perrigo CompanyN0113-2417-01
PerrigoNAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDEnaproxen sodium; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL076518ANDABayer HealthCare LLC.N0280-6045-10
PerrigoNAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDEnaproxen sodium; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL076518ANDABayer HealthCare LLC.N0280-6090-20
PerrigoNAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDEnaproxen sodium; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL076518ANDABayer HealthCare LLC.N0280-6090-10
PerrigoNAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDEnaproxen sodium; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL076518ANDAWalgreen CompanyN0363-0650-01
PerrigoNAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDEnaproxen sodium; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL076518ANDATarget CorporationN11673-417-01
PerrigoNAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDEnaproxen sodium; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL076518ANDATopco Associates LLCN36800-417-52
PerrigoNAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDEnaproxen sodium; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL076518ANDATopco Associates LLCN36800-417-01
PerrigoNAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDEnaproxen sodium; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL076518ANDAMeijer Distribution IncN41250-417-01
PerrigoNAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDEnaproxen sodium; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL076518ANDAHyVee IncN42507-417-01
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Baxter
Boehringer Ingelheim
Novartis
Cerilliant
QuintilesIMS
Covington
Merck
US Department of Justice

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot